WRN inhibitor 14 (S35) is an orally bioavailable small molecule targeting the WRN helicase for cancer research. It demonstrates in vivo efficacy by inhibiting tumor growth in SW48 xenograft models in mice, supporting its study in microsatellite unstable (MSI) cancers.
Molekulargewicht:
756.75
Formel:
C35H40F4N10O5
Target-Kategorie:
DNA/RNA Synthesis
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
